<DOC>
	<DOC>NCT02273505</DOC>
	<brief_summary>Comparative Pharmacokinetics of Asasantin Extended Release (ER) and of immediate release Persantin tablets combined with Acetyl salicylic acid (ASA) tablets</brief_summary>
	<brief_title>Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<mesh_term>Dipyridamole</mesh_term>
	<mesh_term>Aspirin, Dipyridamole Drug Combination</mesh_term>
	<mesh_term>Salicylic Acid</mesh_term>
	<criteria>Healthy subjects as determined by results of screening Signed informed consent in accordance with Good Clinical Practice (GCP) and local legislation Age &gt;= 18 and &lt;= 55 years Broca &gt;= 20% and &lt;= + 20% Any findings of the medical examination (including blood pressure, pulse rate and ECG) deviating from normal and of clinical relevance Gastrointestinal, hepatic, renal, respiratory, cardiovascular, metabolic, immunological or hormonal disorder Surgery of the gastrointestinal tract (except appendectomy) Diseases of the central nervous system (such as epilepsy) or psychiatric disorders or neurological disorders Chronic or relevant acute infections History or hypersensitivity to Asasantin ER and any of the excipients Intake of drugs with a long halflife (&gt; 24 hours) (&lt;= 1 month prior to administration or during the trial) Use of any drugs which might influence the result of the trial (&lt;= 10 days prior to administration or during the trial) Participation in another trial with an investigational drug (&lt;= 1 month prior to administration or during the trial) Known alcohol abuse Known drug abuse Blood donation ( &lt;=1 month prior to administration or during the trial) Excessive physical activities (&lt;=5 days prior to administration or during the trial) History of hemorrhagic diseases History of gastrointestinal ulcer, perforation or bleeding History of bronchial asthma Any laboratory value outside the reference range of clinical relevance For female subjects: Pregnancy Positive pregnant test No adequate contraception (adequate contraception e.g. sterilization, intrauterine device (IUD), oral contraceptives) Inability to maintain this adequate contraception during the whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>